Health News

FDA fast-tracks popularity of Alzheimer’s drug

FDA fast-tracks popularity of Alzheimer’s drug – CBS News


Watch CBS News



The Food and Drug Administration approved a new Alzheimer’s drug called Leqembi, that has been shown to slow the decline in memory and thinking. The medication costs more than $26,000 per year.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.



Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button